149 related articles for article (PubMed ID: 18467380)
1. PD98059 enhances C2 myoblast differentiation through p38 MAPK activation: a novel role for PD98059.
Al-Shanti N; Stewart CE
J Endocrinol; 2008 Jul; 198(1):243-52. PubMed ID: 18467380
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor (IGF)-binding protein-related protein-1: an autocrine/paracrine factor that inhibits skeletal myoblast differentiation but permits proliferation in response to IGF.
Haugk KL; Wilson HM; Swisshelm K; Quinn LS
Endocrinology; 2000 Jan; 141(1):100-10. PubMed ID: 10614628
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
Halevy O; Cantley LC
Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
[TBL] [Abstract][Full Text] [Related]
4. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
Riuzzi F; Sorci G; Donato R
J Cell Physiol; 2006 May; 207(2):461-70. PubMed ID: 16419039
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2.
Weyman CM; Wolfman A
Endocrinology; 1998 Apr; 139(4):1794-800. PubMed ID: 9528964
[TBL] [Abstract][Full Text] [Related]
6. [Effect of IGF-1 on proliferation and differentiation of primary human embryonic myoblasts].
Cen S; Zhang J; Huang F; Yang Z; Xie H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jan; 22(1):84-7. PubMed ID: 18361246
[TBL] [Abstract][Full Text] [Related]
7. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
8. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
Sharples AP; Al-Shanti N; Stewart CE
J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells.
Seto-Young D; Avtanski D; Varadinova M; Park A; Suwandhi P; Leiser A; Parikh G; Poretsky L
Horm Metab Res; 2011 Jun; 43(6):386-90. PubMed ID: 21448845
[TBL] [Abstract][Full Text] [Related]
10. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
11. Early stimulation and late inhibition of extracellular signal-regulated kinase 1/2 phosphorylation by IGF-I: a potential mechanism mediating the switch in IGF-I action on skeletal muscle cell differentiation.
Adi S; Bin-Abbas B; Wu NY; Rosenthal SM
Endocrinology; 2002 Feb; 143(2):511-6. PubMed ID: 11796505
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of C2C12 myoblasts expressing lamin A mutated at a site responsible for Emery-Dreifuss muscular dystrophy is improved by inhibition of the MEK-ERK pathway and stimulation of the PI3-kinase pathway.
Favreau C; Delbarre E; Courvalin JC; Buendia B
Exp Cell Res; 2008 Apr; 314(6):1392-405. PubMed ID: 18294630
[TBL] [Abstract][Full Text] [Related]
13. Beneficial synergistic interactions of TNF-alpha and IL-6 in C2 skeletal myoblasts--potential cross-talk with IGF system.
Al-Shanti N; Saini A; Faulkner SH; Stewart CE
Growth Factors; 2008 Apr; 26(2):61-73. PubMed ID: 18428025
[TBL] [Abstract][Full Text] [Related]
14. Raf-1 activation stimulates proliferation and inhibits IGF-stimulated differentiation in L6A1 myoblasts.
Samuel DS; Ewton DZ; Coolican SA; Petley TD; McWade FJ; Florini JR
Horm Metab Res; 1999; 31(2-3):55-64. PubMed ID: 10226782
[TBL] [Abstract][Full Text] [Related]
15. Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and Akt/PKB pathways.
Deldicque L; Theisen D; Bertrand L; Hespel P; Hue L; Francaux M
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1263-71. PubMed ID: 17652429
[TBL] [Abstract][Full Text] [Related]
16. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
Lin CW; Yang LY; Shen SC; Chen YC
J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
[TBL] [Abstract][Full Text] [Related]
17. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
18. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
Saini A; Al-Shanti N; Sharples AP; Stewart CE
Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
[TBL] [Abstract][Full Text] [Related]
19. The role of mitogen-activated protein kinase in insulin and insulin-like growth factor I (IGF-I) signaling cascades for progesterone and IGF-binding protein-1 production in human granulosa cells.
Seto-Young D; Zajac J; Liu HC; Rosenwaks Z; Poretsky L
J Clin Endocrinol Metab; 2003 Jul; 88(7):3385-91. PubMed ID: 12843192
[TBL] [Abstract][Full Text] [Related]
20. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.
Zhang W; Lee JC; Kumar S; Gowen M
J Bone Miner Res; 1999 Apr; 14(4):528-35. PubMed ID: 10234573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
